Agenzia Italiana del Farmaco
Monitoring of monoclonal antibodies for COVID-19: weekly report published - Monitoring of monoclonal antibodies for COVID-19: weekly report published
Monitoring of monoclonal antibodies for COVID-19: weekly report published
AIFA publishes the results of the monitoring related to monoclonal antibodies for the treatment of COVID-19 currently available. The monitoring is carried out through the AIFA Register developed in implementation of the Decree of the Ministry of Health of 6 February 2021 (published in the Italian Official Journal general series no. 32 of 8/2/21).
The centres enabled by the Regions to fill in the AIFA Register are available on the page "Centres enabled mAb COVID-19" accessible from the box "Related links".
Published on: 27 January 2022